Long-COVID and long-term cancer survivorship—Shared lessons and opportunities
European Journal of Cancer Care
cancer, cancer survivorship, COVID-19
As of 2022, close to 90 million persons in the United States, 243 million persons in Europe and 585 million worldwide have been infected with the novel SARS-CoV-2 (COVID-19) virus and survived. Estimates vary but suggest that up to 50% may experience long-term sequelae, termed ‘Long-COVID’. While Long-COVID is a new condition, the phenomenon of disabling long-term effects following an illness requiring ongoing surveillance and management is not. In this commentary, we discuss how Long-COVID parallels the experiences of long-term cancer survivors, highlight shared challenges and offer opportunities to improve research and clinical care for both growing populations of patients as well as other long-term chronic, disabling conditions.
Harada, T., Schmitz, K., Helsper, C., Campbell, G., & Nekhlyudov, L. (2022). Long-COVID and long-term cancer survivorship—Shared lessons and opportunities. European Journal of Cancer Care. https://doi.org/10.1111/ecc.13712